- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
CBO projects lower ACA enrollment
Estimates show a reduction in expected coverage levels in 2014.
An updated estimate of the amount of people expected to enroll in health insurance coverage through the exchanges in 2014 was released today in a
by the Congressional Budget Office (CBO). Estimates show a reduction in expected coverage levels in 2014.
Key findings:
- The projected exchange enrollment in 2014 dropped from 7 million to 6 million;
- The projected enrollment in Medicaid and The Children's Health Insurance Program (CHIP) in 2014 dropped from 9 million to 8 million;
- The number of uninsured Americans in 2014 increased by 1 million; and
- The estimates of the net impact of the Affordable Care Act on employment-based coverage stayed the same.
Additional points of interest include:
- CBO predicts that about 83% of exchange enrollees in 2014 will receive a subsidy;
- Estimated average premiums were lowered by about 15%; and
- Findings showed that risk corridor payments will yield $8 billion in savings for the federal governement.
The report cites a recent Department of Health and Human Services enrollment
report
, which includes exchange enrollment data through December 28, 2013.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients
July 22nd 2020MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.
Listen
